Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Metastases to lymph nodes
ADR ID BADD_A07418
ADR Hierarchy
01      Blood and lymphatic system disorders
01.09      Spleen, lymphatic and reticuloendothelial system disorders
01.09.01      Lymphatic system disorders NEC
01.09.01.015      Metastases to lymph nodes
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.02      Metastases to specified sites
16.22.02.006      Metastases to lymph nodes
Description Not Available
MedDRA Code 10027459
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Axillary metastases | Lymph node metastases | Metastases to lymph nodes | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes | Secondary and unspecified malignant neoplasm of lymph nodes | Secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb | Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck | Secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb. | Secondary and unspecified malignant neoplasm of lymph nodes of multiple sites | Secondary and unspecified malignant neoplasm of lymph nodes, site unspecified | Troisier's sign | Virchow's node
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.000576%
BADD_D00047Afatinib0.000347%
BADD_D00142Anastrozole0.000787%
BADD_D00195Azathioprine0.000562%
BADD_D00271Bicalutamide0.004203%
BADD_D00349Capecitabine0.000208%
BADD_D00364Carboplatin0.000208%
BADD_D00414Ceritinib0.000139%
BADD_D00474Cisplatin0.000486%
BADD_D00511Clozapine0.005117%
BADD_D00551Cyclosporine0.000203%
BADD_D00589Dasatinib0.000139%
BADD_D00699Docetaxel0.000139%
BADD_D00723Doxorubicin0.000208%
BADD_D00736Dutasteride0.000408%
BADD_D00775Enzalutamide0.000576%
BADD_D00800Erlotinib0.000208%
BADD_D00858Everolimus0.001428%
BADD_D00931Fluorouracil0.000368%
BADD_D00978Fulvestrant0.001535%
BADD_D01008Gefitinib0.000208%
BADD_D01110Hydroxyurea0.000139%
BADD_D01136Imatinib0.000764%
BADD_D01257Letrozole0.002247%
BADD_D01258Leucovorin0.002282%
BADD_D01281Levonorgestrel--
BADD_D01567Nilotinib0.000139%
BADD_D01601Olaparib0.000417%
BADD_D01629Osimertinib0.000764%
BADD_D01633Oxaliplatin0.000208%
The 1th Page    1 2    Next   Last    Total 2 Pages